Opinion about seasonal influenza vaccination among the general population 3 years after the A(H1N1)pdm2009 influenza pandemic

Boiron, Karine; Sarazin, Marianne; Debin, Marion; Raude, Jocelyn; Rossignol, Louise; Guerrisi, Caroline; Odinkemelu, Didi; Hanslik, Thomas; Colizza, Vittoria; Blanchon, Thierry

doi:10.1016/j.vaccine.2015.08.067

Cited by 16 publications

(15 citation statements)

References 33 publications

(27 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…But distrust in distal stakeholders — the French government and pharmaceutical companies — was more marked in unvaccinated than vaccinated patients. Management of the 2009 A/H1N1 pandemic, by what the public perceived as exaggeration of the risks and minimisation of the agency of the population, probably impaired the credibility of those stakeholders, including for the information they disseminate about SIV [ 12 , 38 ]. SIV uptake decreased steeply after the 2009 A/H1N1 pandemic and has continued to drop since then [ 6 ].…”

Section: Discussionmentioning

confidence: 99%

“…This effectiveness for the oldest patients and those with chronic diseases remains debated among scientists [ 10 , 11 ]. Negative opinions about SIV were revived during the pandemic A/H1N1 mass vaccination campaign, in France especially [ 12 ]. Far fewer studies have examined the factors associated with SIV uptake among people with chronic conditions such as diabetes than among the general population.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Flu vaccination among patients with diabetes: motives, perceptions, trust, and risk culture - a qualitative survey

et al. 2018

View full text Add to dashboard Cite

BackgroundVaccination against seasonal influenza (SIV) is recommended for patients with diabetes, but their vaccination coverage is unsatisfactory in France and elsewhere. This qualitative survey of people with diabetes sought to explore 1) the extent to which SIV-related behaviour is more or less automatic; 2) reasons they choose/reject SIV; 3) their trust/distrust in authorities, science, and medicine.MethodsWe conducted semi-structured in-depth interviews of 19 adults with diabetes in 2014. We recruited them through physicians or patient associations and implemented an analysis of thematic content.ResultsEight patients were vaccinated against flu in the preceding flu season and 11 were not. SIV uptake and refusal were stable over time and justified by multiple arguments. Coupons for free vaccines and regular doctor visits contributed to the habit of vaccination. Vaccination decisions were frequently anchored in past experiences of influenza and its vaccine. Patients often justified non-vaccination with attitudes of trivialisation/relativisation of influenza-associated risks and the perception that these can be controlled by means other than vaccination (e.g., through the avoidance of exposure). Some misbeliefs (e.g., SIV causes influenza) and doubts about SIV effectiveness and safety also existed. Several patients reported increased mistrust of SIV since the A/H1N1 pandemic in 2009. Patients trusted their doctors strongly regardless of their SIV behaviour, but unvaccinated patients had little trust in the government and pharmaceutical companies. Some discordances were found between perceptions and behaviour (e.g., remaining vaccinated despite doubts about SIV effectiveness or remaining unvaccinated despite feelings of vulnerability towards influenza complication), suggesting the existence of some vaccine hesitancy among patients.ConclusionThis study among patients with diabetes suggest that SIV uptake is stable, thanks to a favourable environment. Nonetheless, SIV refusal is also stable over time. Unvaccinated patients used multiple arguments to justify SIV refusal, including compensatory health beliefs. Physicians should take every opportunity to recommend SIV. The necessary individualised patient education regarding SIV requires better physician training in patients priorities. While almost all patients strongly trust their doctors, unvaccinated patients distrust distal stakeholders: it is absolutely essential to restore trust in them and to develop new more effective influenza vaccines.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Flu vaccination among patients with diabetes: motives, perceptions, trust, and risk culture - a qualitative survey

et al. 2018

View full text Add to dashboard Cite

show abstract

“…The accelerated authorisation procedure to market pandemic vaccines called their efficacy and safety into question, as well as the actual motivations of pharmaceutical firms. Moreover, the public health authorities lost credibility because of the contrast between the large size of the vaccination campaign and the small proportion of the population that was actually vaccinated during the pandemic [7]. Information sources used by the general population may also influence beliefs about vaccine safety and efficacy, attitude towards vaccination and the level of knowledge about vaccines [8-10].…”

Section: Introductionmentioning

confidence: 99%

Population perception of mandatory childhood vaccination programme before its implementation, France, 2017

et al. 2019

Self Cite

View full text Add to dashboard Cite

Background Vaccination policy in France was previously characterised by the coexistence of eight recommended and three mandatory vaccinations for children younger than 2 years old. These 11 vaccines are now mandatory for all children born after 1 January 2018. Aim To study the French population’s opinion about this new policy and to assess factors associated with a positive opinion during this changing phase. Methods A cross-sectional survey about vaccination was conducted from 16 November–19 December 2017 among the GrippeNet.fr cohort. Data were weighted for age, sex and education according to the French population. Univariate and multivariate analyses were performed to identify factors associated with a favourable opinion on mandatory vaccines’ extension and defined in the ‘3Cs’ model by the World Health Organization Strategic Advisory Group of Experts working group on vaccine hesitancy. Results Of the 3,222 participants (response rate 50.5%) and after adjustment, 64.5% agreed with the extension of mandatory vaccines. It was considered a necessary step by 68.7% of the study population, while 33.8% considered it unsafe for children and 56.9% saw it as authoritarian. Factors associated with a positive opinion about the extension of mandatory vaccines were components of the confidence, complacency and convenience dimensions of the ‘3Cs’ model. Conclusions In our sample, two thirds of the French population was in favour of the extension of mandatory vaccines for children. Perception of vaccine safety and benefits were major predictors for positive and negative opinions about this new policy.

show abstract

“…Following the “swine flu” influenza pandemic of 2009, the public now recognises influenza as a serious disease, rather than the previous tendency to dismiss any mild viral infection as a “touch of the flu.” However, public perception of the hazards of influenza are still associated with the extremes of devastating pandemics such as the Spanish influenza outbreak of 1918, which was responsible for 50‐100 million deaths. More recently, the “swine flu” influenza pandemic of 2009, despite never realising such a dramatic toll, was still associated with an estimated 284 000 deaths in the first year .…”

Section: Introductionmentioning

confidence: 99%

Seasonal influenza immunisation: Strategies for older adults

et al. 2018

View full text Add to dashboard Cite

Adults over the age of 60-65 years suffer disproportionally from seasonal influenza, experiencing high rates of complications, exacerbation of underlying medical comorbidities, and excess mortality. Thus, older adults are an important priority for influenza immunisation campaigns. Unfortunately, older adults generally display lower immune responses to standard influenza vaccines because of immunosenescence, with resulting suboptimal vaccine effectiveness. Thus, the development of improved vaccines that heighten immune responses and improve effectiveness is an important medical need. To this end, enhanced influenza vaccines specifically targeting this age group have been developed, which seek to overcome the inherent limitations in the immune responses of older adults. Both the licensed high-dose trivalent influenza vaccine (hdTIV) containing fourfold higher antigen contents than standard vaccine, and the MF59 -adjuvanted trivalent influenza vaccine (aTIV) have been proven to be safe and well-tolerated while enhancing the immune response. Healthcare providers for populations of older adults should be advised to routinely use these enhanced influenza vaccines in seasonal immunisation campaigns to provide improved immunity against influenza and its consequences in this particularly susceptible age group.

show abstract

Opinion about seasonal influenza vaccination among the general population 3 years after the A(H1N1)pdm2009 influenza pandemic

Cited by 16 publications

References 33 publications

Flu vaccination among patients with diabetes: motives, perceptions, trust, and risk culture - a qualitative survey

Flu vaccination among patients with diabetes: motives, perceptions, trust, and risk culture - a qualitative survey

Population perception of mandatory childhood vaccination programme before its implementation, France, 2017

Seasonal influenza immunisation: Strategies for older adults

Contact Info

Product

Resources

About